Nye kombinerte terapeutiske regimer for behandling av B- celle-lymfomer er beskrevet og som omfatter spesielt administrasjon av anti-CD20-antistoff til pasienter som har lav-, mellomliggende- eller høygrads non-Hodgkins lymfom.
IPC class
CPC class
Sender
Org. number: 910476068
Status history for 2016/01675
| Legal status | Decision date, detailed status |
|---|---|
| Settled | Request completed |
| Pending | Received at office |
Correspondence for 2016/01675
|
Date
Correspondence type
Journal description
|
|---|
|
Outgoing
GH Forespørsel
|
|
Outgoing
GH Forespørsel
|
|
Incoming
E-post
|
Agent in Norway:
Org. number: 910476068
- Org. number:
- Organization name:
- Organization form:
- Industry:
-
Organization address:
1998.08.11, US 96180
US 5736137 A (A)
MALONEY, D.G. et al,IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed Non-Hodgkin's lymphoma. Jour. of Clinic. Oncol., 1997.10, Vol. 15, No. 10, s. 3266-74 ()
MCLAUGHLIN, P. et al, Rituximab chimeric anti-CD20 monoklonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. 1998.08, Vol. 16, No. 8, s. 2825-33 ()
VAN DER KOLK, L.E. et al., Chimeric anti-CD20 monoklonal antibody (Rituximab) plus G-CSF in relapsed B-cell lymphoma: A phase I/II clinical trial, 1998.07.01, Brit. Jour. of haematol., Vol. 102, No. 1, sammendrag ()
US 5736137 A (A)
MALONEY, D.G. et al. IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed Non-Hodgkin's lymphoma. Jour. of Clinic. Oncol., 1997.10, Vol. 15, No. 10, s. 3266-74, ()
MCLAUGHLIN, P. et al. Rituximab chimeric anti-CD20 monoklonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. 1998.08, Vol. 16, No. 8, s. 2825-33, ()
VAN DER KOLK, L.E. et al.Chimeric anti-CD20 monoklonal antibody (Rituximab) plus G-CSF in relapsed B-cell lymphoma: A phase I/II clinical trial, 1998.07.01, Brit. Jour. of haematol., Vol. 102, No. 1. ()
ARRANZ REYES, ET AL., Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization. Jour. Clin. Oncol. April 1998; Vol. 16(4), s. 1538-46. ()
Hochster, H. S. ET AL., Maintenance Rituximab after CVP Results in Superior Clinical Outcome in Advanced Follicular Lymphoma (FL): Results of the E1496 Phase III Trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B. Blood (ASH Annual Meeting Abstracts), 2005, 106: Abstract 349. ()
Claimant
Org. number: 910476068
- Org. number:
- Organization name:
- Organization form:
- Industry:
-
Organization address:
Claimant's agent
Org. number: 910476068
- Org. number:
- Organization name:
- Organization form:
- Industry:
-
Organization address:
Status history for 2017/00085
| Legal status | Decision date, detailed status |
|---|---|
| Performed | The right has been changed as a result of administrative review or patent limitation |
| Pending | Letter with due date issued |
| Pending | Letter with due date issued |
| Pending | Received |
Correspondence for 2017/00085
|
Date
Correspondence type
Journal description
|
|---|
|
Outgoing
OP10: Oversendelsesbrev med avgjørelse uten klagefrist
|
|
Incoming, AR186070508
Korrespondanse (Hovedbrev inn)
|
|
Outgoing
Mangelbrev
|
|
Incoming, AR185167762
Korrespondanse (Hovedbrev inn)
|
|
Incoming, AR184889052
Nytt overprøvningskrav (OP)
|
Status history
| Legal status | Decision date, detailed status |
|---|---|
| Granted | Granted (B3) with changes after administrative overruling or administrative reevaluation |
| Granted | Message about invalidation case or transfer of patent case for court has been received. |
| Granted | Granted (B1) |
| Pending | Accepted for grant |
| Pending | Second and later letter exists |
| Pending | Second and later letter exists |
| Pending | Second and later letter exists |
| Pending | Second and later letter exists |
| Pending | Case handling is resumed |
| Shelved | Not answered in due time (PL § 15) |
| Pending | Second and later letter exists |
| Pending | First letter of examination exists |
| Pending | New application created |
Correspondence
|
Date
Correspondence type
Journal description
|
|---|
|
Incoming, AR184889052
Krav
|
|
Outgoing
Bekreftelse mottatt melding om søksmål
|
|
Incoming
Melding om søksmål
|
|
Outgoing
PT Registreringsbrev Nasjonal Patent
|
|
Outgoing
PT Meddelelse om patent
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Outgoing
Realitet patent
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Outgoing
Realitet patent
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Outgoing
Realitet patent
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Outgoing
Realitet patent
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Outgoing
Henlagt manglende svar
|
|
Outgoing
Henlagt manglende svar
|
|
Outgoing
Realitet patent
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Incoming
Korrespondanse (hoved dok)
|
|
Outgoing
PT Realitet_patent (2009.04.01)
|
Payment due:
Payment history:
| Description / Invoice number Payment date Amount Payer Status | ||||
|---|---|---|---|---|
| Annual fee 20th year 2018.07.26 6500 MASTER DATA INC | ||||
| Annual fee 19th year 2017.07.26 6200 MASTER DATA INC Paid and approved | ||||
| Annual fee 18th year 2016.07.25 5800 MASTER DATA INC Paid and approved | ||||
| Annual fee 17th year 2015.07.27 5500 Master Data Center Inc Paid and approved | ||||
| Annual fee 16th year 2014.07.25 5200 Master Data Center Inc Paid and approved | ||||
| Annual fee 15th year 2013.07.26 4400 Master Data Center Inc Paid and approved | ||||
| 31213747 2012.11.09 7100 Oslo Patentkontor AS Paid | ||||
|
Granting fee patent
1100 = 1 X 1100
Additional granting fee > 14 pages
6000 = 24 X 250
|
||||
| Annual fee 14th year 2012.08.09 4100 Computer Patent Annuities Ltd Paid and approved | ||||
| Annual fee 13th year 2011.07.20 3800 Computer Packages Inc Paid and approved | ||||
| 31013977 2010.12.07 900 Oslo Patentkontor AS Paid | ||||
|
1st Resumption fee, patent
900 = 1 X 900
|
||||
| Annual fee 12th year 2010.07.21 2850 Computer Packages Inc Paid and approved | ||||
| Annual fee 11th year 2009.07.21 2850 Computer Packages Inc | ||||
| Annual fee 10th year 2008.07.21 2850 Computer Packages Inc | ||||
| Annual fee 9th year 2007.07.19 1900 Computer Packages Inc | ||||
| Annual fee 8th year 2006.07.19 1900 Computer Packages Inc | ||||
| Annual fee 7th year 2005.07.21 1900 Computer Packages Inc | ||||
| Annual fee 6th year 2004.08.11 1000 Computer Patent Annuities Ltd | ||||
| 0 | ||||
| 0 | ||||
| 0 | ||||
Links to publications and the Norwegian Patent Gazette (searchable text documents)
Links to publications (only image files)
What does A1, B, B1, C stand for?
